Health
Donor stem cell transplant can improve survival rates for older patients with MDS, study shows – News-Medical.Net
A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk…
A new clinical trial offers the most compelling evidence to date that a donor stem cell transplant can improve survival rates for older patients with higher-risk myelodysplastic syndrome (MDS), Dana-Farber Cancer Institute investigators report at the virtual 62nd American Society of Hematology (ASH) Annual Meeting.
Despite being the only current cure for MDS and widely used for younger patients, transplant generally hasn’t been offered to older patients because it has not been proven beneficial…
-
Noosa News22 hours agoMajor crash on Gateway Motorway snarls morning commute
-
Noosa News18 hours agoDriver arrested after life-threatening hit-and-run on outskirts of Ipswich, Queensland
-
Business20 hours agoThis ASX 200 mining stock is eyeing the lithium throne
-
General23 hours agoMelbourne AFLW skipper Kate Hore backs league’s future, citing rising skills and talent